Search Result "sphingomyelinase-treated"
Redistribution of CD95 into the Lipid Rafts to Treat Cancer Cells?
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5 Issue: 1 Year: 2010 Page: 22-28
Author(s): Bruno Segui, Patrick Legembre
Sphingomyelinase Inhibition Suggests a Possible New Strategy for the Treatment of Inflammatory Bowel Disease
Journal: Current Drug Therapy
Volume: 3 Issue: 3 Year: 2008 Page: 218-225
Author(s): Shinji Soeda, Akira Sakata, Takashi Ochiai, Kazuya Yasuda, Yukako Kuramoto, Hiroshi Shimeno, Akihisa Toda, Reiko Eyanagi, Sadao Hikishima, Tsutomu Yokomastu, Shirashi Shibuya
Lipid Rafts and Redox Regulation of Cellular Signaling in Cholesterol Induced Atherosclerosis
Journal: Current Cardiology Reviews
Volume: 6 Issue: 4 Year: 2010 Page: 309-324
Author(s): Betul Catalgol, Nesrin Kartal Ozer
Artemisinin Delays Sphingolipid Biosynthesis in Plasmodium falciparum
Journal: Letters in Drug Design & Discovery
Volume: 4 Issue: 7 Year: 2007 Page: 524-526
Author(s): Francoise Debierre-Grockiego, Jorg Schmidt, Eliezer Flescher, Ralph T. Schwarz
Ceramide in Chemotherapy of Tumors
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 3 Year: 2011 Page: 284-293
Author(s): Marie-Therese Dimanche-Boitrel, Amelie Rebillard, Erich Gulbins
Sphingolipid Turnover Inhibitors as Modulators of Cellular Metabolism and Obesity
Ebook: Anti-Obesity Drug Discovery and Development
Volume: 2 Year: 2014
Author(s): Nataliya A. Babenko
Doi: 10.2174/9781608059140114020007
Inhibition of Sphingomyelin Hydrolysis: Targeting the Lipid Mediator Ceramide as a Key Regulator of Cellular Fate
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 1 Year: 2009 Page: 1978-2000
Author(s): Ralf A. Claus, Michael J. Dorer, Alexander C. Bunck, H. Peter Deigner
Current Status and Perspectives in Ceramide-Targeting Molecular Medicine
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 1 Year: 2005 Page: 2479-2487
Author(s): Hirofumi Sawai, Naochika Domae, Toshiro Okazaki
Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 4 Year: 2012 Page: 340-363
Author(s): Thomas D. Mullen,Lina M. Obeid
Hepatocarcinogenesis and Ceramide/Cholesterol Metabolism
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 4 Year: 2012 Page: 364-375
Author(s): Albert Morales,Montserrat Mari,Carmen Garcia-Ruiz,Anna Colell,Jose C. Fernandez-Checa